Preliminary results from RESET-RA Study announced; demonstrating ACR20 efficacy of implanted vagal nerve stimulation at 12 wks (p=0.0209). 2-staged, multicenter, randomized, sham-controlled, double-blind pivotal trial, enrolled 242 RA pts https://t.co/gIVJd9F6Pk https://t.co/SNjWIa3raB
Links:
SetPoint Medical Announces Positive Topline Results from Landmark RESET-RA Stud…
https://buff.ly/3LmLQWR
Jul-14-2024


